Clinical Focus ›› 2021, Vol. 36 ›› Issue (12): 1087-1091.doi: 10.3969/j.issn.1004-583X.2021.12.006
Previous Articles Next Articles
Lu Xunda, Feng Zhijie, Ji Chenguang, Yin Kaige, Liu Li()
Received:
2021-09-08
Online:
2021-12-20
Published:
2021-12-24
Contact:
Liu Li
E-mail:loraliu@163.com
CLC Number:
Lu Xunda, Feng Zhijie, Ji Chenguang, Yin Kaige, Liu Li. Analysis on risk factors of postoperative hemorrhage of endoscopic submucosal dissection in early gastric cancer[J]. Clinical Focus, 2021, 36(12): 1087-1091.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.12.006
项目 | 未出血组 (n=265) | 出血组 (n=16) | χ2值 | P值 |
---|---|---|---|---|
性别 | ||||
女 男 | 45(17.0) 220(83.0) | 2(12.5) 14(87.5) | 0.218 | 0.64 |
年龄 | ||||
<60岁 ≥60岁 | 90(34.0) 175(66.0) | 9(35.2) 7(64.8) | 3.285 | 0.07 |
应用抗血小板药 | ||||
否 是 | 256(96.6) 9(3.4) | 12(75.0) 4(25.0) | 15.961 | <0.01 |
合并高血压 | ||||
否 是 | 204(77.0) 61(23.0) | 11(68.8) 5(31.3) | 0.569 | 0.45 |
合并糖尿病 | ||||
否 是 | 228(86.0) 37(14.0) | 14(87.5) 2(12.5) | 0.027 | 0.87 |
合并缺血性血管病 | ||||
否 是 | 228(86.0) 37(14.0) | 13(81.3) 3(18.8) | 0.283 | 0.60 |
项目 | 未出血组 (n=265) | 出血组 (n=16) | χ2值 | P值 |
---|---|---|---|---|
性别 | ||||
女 男 | 45(17.0) 220(83.0) | 2(12.5) 14(87.5) | 0.218 | 0.64 |
年龄 | ||||
<60岁 ≥60岁 | 90(34.0) 175(66.0) | 9(35.2) 7(64.8) | 3.285 | 0.07 |
应用抗血小板药 | ||||
否 是 | 256(96.6) 9(3.4) | 12(75.0) 4(25.0) | 15.961 | <0.01 |
合并高血压 | ||||
否 是 | 204(77.0) 61(23.0) | 11(68.8) 5(31.3) | 0.569 | 0.45 |
合并糖尿病 | ||||
否 是 | 228(86.0) 37(14.0) | 14(87.5) 2(12.5) | 0.027 | 0.87 |
合并缺血性血管病 | ||||
否 是 | 228(86.0) 37(14.0) | 13(81.3) 3(18.8) | 0.283 | 0.60 |
变量 | 未出血组 (n=265) | 出血组 (n=16) | χ2值 | P值 |
---|---|---|---|---|
手术时间 | ||||
<2 h ≥2 h | 195(73.6) 70(26.4) | 3(18.8) 13(81.3) | 21.799 | <0.01 |
大体分型 | ||||
Ⅰ | 14(5.3) | 0 | ||
Ⅱa | 23(8.7) | 1(6.3) | ||
Ⅱb | 79(29.8) | 5(31.3) | ||
Ⅱc | 77(29.1) | 3(18.8) | 5.282 | 0.63 |
Ⅱa+Ⅱb | 9(3.4) | 1(6.3) | ||
Ⅱa+Ⅱc | 50(18.9) | 6(37.5) | ||
Ⅱb+Ⅱc | 3(1.1) | 0 | ||
Ⅲ | 10(3.8) | 0 | ||
病变部位 | ||||
上1/3 | 186(70.2) | 9(56.3) | ||
中1/3 | 31(11.7) | 3(18.8) | 1.429 | 0.489 |
下1/3 | 48(18.1) | 4(25.0) | ||
肿瘤直径 | ||||
<30 mm ≥30 mm | 178(67.2) 87(32.8) | 9(56.3) 7(43.8) | 0.808 | 0.37 |
浸润深度 | ||||
M | 178(67.2) | 13(81.3) | ||
SM1 | 53(20.0) | 1(6.3) | 1.926 | 0.38 |
SM2 | 34(12.8) | 2(12.5) | ||
溃疡 | ||||
无 有 | 252(95.1) 13(4.9) | 11(68.8) 5(31.3) | 17.467 | <0.01 |
完全切除 | ||||
否 是 | 45(17.0) 220(83.0) | 2(12.5) 14(87.5) | 0.218 | 0.64 |
整块切除 | ||||
否 是 | 2(0.8) 263(99.2) | 0 16(100.0) | 0.122 | 0.73 |
脉管侵犯 | ||||
否 是 | 261(98.5) 4(1.5) | 16(100.0) 0 | 0.245 | 0.62 |
变量 | 未出血组 (n=265) | 出血组 (n=16) | χ2值 | P值 |
---|---|---|---|---|
手术时间 | ||||
<2 h ≥2 h | 195(73.6) 70(26.4) | 3(18.8) 13(81.3) | 21.799 | <0.01 |
大体分型 | ||||
Ⅰ | 14(5.3) | 0 | ||
Ⅱa | 23(8.7) | 1(6.3) | ||
Ⅱb | 79(29.8) | 5(31.3) | ||
Ⅱc | 77(29.1) | 3(18.8) | 5.282 | 0.63 |
Ⅱa+Ⅱb | 9(3.4) | 1(6.3) | ||
Ⅱa+Ⅱc | 50(18.9) | 6(37.5) | ||
Ⅱb+Ⅱc | 3(1.1) | 0 | ||
Ⅲ | 10(3.8) | 0 | ||
病变部位 | ||||
上1/3 | 186(70.2) | 9(56.3) | ||
中1/3 | 31(11.7) | 3(18.8) | 1.429 | 0.489 |
下1/3 | 48(18.1) | 4(25.0) | ||
肿瘤直径 | ||||
<30 mm ≥30 mm | 178(67.2) 87(32.8) | 9(56.3) 7(43.8) | 0.808 | 0.37 |
浸润深度 | ||||
M | 178(67.2) | 13(81.3) | ||
SM1 | 53(20.0) | 1(6.3) | 1.926 | 0.38 |
SM2 | 34(12.8) | 2(12.5) | ||
溃疡 | ||||
无 有 | 252(95.1) 13(4.9) | 11(68.8) 5(31.3) | 17.467 | <0.01 |
完全切除 | ||||
否 是 | 45(17.0) 220(83.0) | 2(12.5) 14(87.5) | 0.218 | 0.64 |
整块切除 | ||||
否 是 | 2(0.8) 263(99.2) | 0 16(100.0) | 0.122 | 0.73 |
脉管侵犯 | ||||
否 是 | 261(98.5) 4(1.5) | 16(100.0) 0 | 0.245 | 0.62 |
自变量 | 回归 系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||
应用抗血小板药 | -3.033 | 0.866 | 12.264 | <0.01 | 0.051 | 0.011 | 0.230 |
手术时间 | -2.970 | 0.765 | 15.072 | <0.01 | 0.048 | 0.009 | 0.263 |
溃疡 | -3.278 | 0.832 | 15.511 | <0.01 | 0.038 | 0.007 | 0.193 |
自变量 | 回归 系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI | |
---|---|---|---|---|---|---|---|
下限 | 上限 | ||||||
应用抗血小板药 | -3.033 | 0.866 | 12.264 | <0.01 | 0.051 | 0.011 | 0.230 |
手术时间 | -2.970 | 0.765 | 15.072 | <0.01 | 0.048 | 0.009 | 0.263 |
溃疡 | -3.278 | 0.832 | 15.511 | <0.01 | 0.038 | 0.007 | 0.193 |
[1] |
Bialek A, Wiechowska-Kozlowska A, Pertkiewicz J, et al. Endoscopic submucosal dissection for the treatment of neoplastic lesions in the gastrointestinal tract[J]. World J Gastroenterol, 2013, 19(12):1953-1961.
doi: 10.3748/wjg.v19.i12.1953 URL |
[2] |
Mannen K, Tsunada S, Hara M, et al. Risk factors for complications of endoscopic submucosal dissection in gastric tumors: Analysis of 478 lesions[J]. J Gastroenterol, 2010, 45(1):30-36.
doi: 10.1007/s00535-009-0137-4 URL |
[3] | Mukai S, Cho S, Kotachi T, et al. Analysis of delayed bleeding after endoscopic submucosal dissection for gastric epithelial neoplasms[J]. Gastroenterol Res Pract, 2012 : 875323. |
[4] | 张波, 刘凤林. 早期胃癌内镜黏膜下剥离术相关并发症及其处理原则[J]. 中国实用外科杂志, 2019, 39(5):506-508. |
[5] |
Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract[J]. Endoscopy, 2005, 37(6):570-578.
doi: 10.1055/s-2005-861352 URL |
[6] | 北京市科委重大项目《早期胃癌治疗规范研究》专家组, 柴宁莉, 翟亚奇, 等. 早期胃癌内镜下规范化切除的专家共识意见(2018, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(2):49-60. |
[7] |
Muraki Y, Enomoto S, Iguchi M, et al. Management of bleed-ing and artificial gastric ulcers associated with endoscopic submucosal dissection[J]. World J Gastrointest Endosc, 2012, 4(1):1-8.
doi: 10.4253/wjge.v4.i1.1 URL |
[8] |
Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-An analysis of risk factors[J]. Endoscopy, 2008, 40(3):179-183.
doi: 10.1055/s-2007-995530 pmid: 18322872 |
[9] |
Uedo N, Takeuchi Y, Ishihara R, et al. Endoscopic Doppler US for the prevention of ulcer bleeding after endoscopic submucosal dissection for early gastric cancer: A preliminary study (with video)[J]. Gastrointest Endosc, 2010, 72(2):444-448.
doi: 10.1016/j.gie.2010.03.1128 URL |
[10] |
Choi CW, Kim HW, Kang DH, et al. Clinical outcomes of second-look endoscopy after gastric endoscopic submucosal dissection: Predictive factors with high risks of bleeding[J]. Surg Endosc, 2014, 28(7):2213-2220.
doi: 10.1007/s00464-014-3457-2 URL |
[11] |
Ono S, Ono M, Nakagawa M, et al. Delayed bleeding and hemorrhage of mucosal defects after gastric endoscopic submucosal dissection on second-look endoscopy[J]. Gastric Cancer, 2016, 19(2):561-567.
doi: 10.1007/s10120-015-0507-y URL |
[12] | 国家消化内镜专业质控中心, 国家消化系统疾病临床医学研究中心(上海), 等. 中国内镜黏膜下剥离术相关不良事件防治专家共识意见(2020, 无锡)[J]. 中华消化内镜杂志, 2020, 37(6):390-403. |
[13] |
Kim JH, Nam HS, Choi CW, et al. Risk factors associated with difficult gastric endoscopic submucosal dissection: Predicting difficult ESD[J]. Surg Endosc, 2017, 31(4):1617-1626.
doi: 10.1007/s00464-016-5149-6 pmid: 27495343 |
[14] |
Sanomura Y, Oka S, Tanaka S, et al. Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer[J]. Gastric Cancer, 2013, 17(3):489-496.
doi: 10.1007/s10120-013-0305-3 URL |
[15] | 蔡培, 张妮娜, 李雯, 等. 早期胃癌内镜黏膜下剥离术后出血的危险因素分析[J]. 疑难病杂志, 2021, 20(2):163-166. |
[16] |
Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment[J]. Dig Endosc, 2014, 26(1):1-14.
doi: 10.1111/den.12183 pmid: 24215155 |
[17] |
Tsuji Y, Ohata K, Ito T, et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions[J]. World J Gastroenterol, 2010, 16(23):2913-2917.
doi: 10.3748/wjg.v16.i23.2913 URL |
[18] | Mannen K, Tsunada S, Hara M, et al. Risk factors for complications of endoscopic submucosal dissection in gastric tumors: Analysis of 478 lesions[J]. World J Gastroenterol, 2009, 45(1):30-36. |
[19] |
Ebi M, Shimura T, Nishiwaki H, et al. Management of systolic blood pressure after endoscopic submucosal dissection is crucial for prevention of post-ESD gastric bleeding[J]. Eur J Gastroenterol Hepatol, 2014, 26(5):504-509.
doi: 10.1097/MEG.0000000000000072 URL |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||